Beta Drugs 52-Week High & Low
Beta Drugs (BETA) 52-week high ₹1,743.60 (Dec. 2, 2025), 52-week low ₹1,030.30 (Feb. 25, 2026), current price ₹1,400.70 — 19.7% below 52-week high, 36.0% above 52-week low, range position 51.9% (Mid Range). For full fundamentals, ratios and live price, see BETA share price.
Current Share Price: ₹1,400.70 (NSE)
52-Week High
₹1,743.60
December 02, 2025
19.7% below high
52-Week Low
₹1,030.30
February 25, 2026
36.0% above low
Current Position in 52-Week Range
52W Low
51.9%
52W High
713.30
Range Span (₹)
Mid Range
Position Category
51.9%
Range Position
Position Analysis
Neutral - Trading in middle range, mixed signals
Risk-Reward Analysis
24.5%
Upside Potential
26.4%
Downside Risk
Ratio: 0.93
Poor - High risk vs limited reward
Poor - High risk vs limited reward
Beta Drugs 52-Week Price Chart
BETA daily price over 52 weeks — current ₹1,400.70, high ₹1,743.60, low ₹1,030.30, range span ₹713.30. Review BETA earnings multiple to evaluate earnings-based valuation against sector peers.
Beta Drugs Historical 52-Week High & Low Ranges
BETA annual 52-week high, 52-week low and range span — 2 years of data. Read BETA dividend yield for the complete payout history and dividend yield track record.
2026
52-Week Range
H: ₹1,664.20
L: ₹1,030.30
61.5% Range
2025
52-Week Range
H: ₹1,743.60
L: ₹1,512.80
15.3% Range
BETA vs Healthcare Sector — 52-Week Range Position & Return
Beta Drugs 52-week range position 51.9% vs Healthcare sector average 109.7%, avg 52-week return 75.0% — 1 peers.
109.7%
Sector Avg Position
75.0%
Sector Avg Return
1
Companies
SMS Lifesciences
Position: 109.7% (Near High)
52W Return: 75.0%
Volume Analysis at Extremes
High Volume: 4,916
(0.48x avg) - Low volume at high - weak conviction
Low Volume: 28,458
(2.77x avg) - High volume at low - possible capitulation/reversal
Average Volume: 10,273